Antiaging Quantum Living Inc.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0M | $817.9K | $7.5K | $13.6K | $7.4K | $3.8K | — | — |
| Cost of Revenue | $332.3K | $389.4K | $771 | — | $1.1K | $800 | — | — |
| Gross Profit | $702.1K | $428.5K | $6.7K | $13.6K | $6.3K | $3.0K | — | — |
| Gross Margin | 67.9% | 52.4% | 89.7% | 100.0% | 85.1% | 78.9% | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.4M | $1.1M | $348.5K | $50.2K | $51.3K | $75.9K | $55.4K | $57.0K |
| Operating Income | $-835.4K | $-790.0K | $-413.0K | $-36.6K | $-45.0K | $-72.9K | $-55.4K | $-57.1K |
| Operating Margin | -80.8% | -96.6% | -5,507.6% | -269.3% | -608.2% | -1,919.4% | — | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-821.0K | $-720.4K | $-413.0K | $-36.6K | $-43.4K | $-66.5K | — | — |
| Income Tax Expense | $16.7K | — | — | — | — | — | — | $13.4K |
| Net Income | $-837.6K | $-720.4K | $-413.0K | $-36.6K | $-43.4K | $-66.5K | $-59.1K | $-70.5K |
| Net Margin | -81.0% | -88.1% | -5,507.0% | -269.3% | -587.0% | -1,750.3% | — | — |
| EPS (Basic) | $-0.03 | $-0.02 | $-0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | $-0.03 | $-0.02 | $-0.01 | — | — | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 31.5M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 10.0M |
| Shares Outstanding (Diluted) | 31.5M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 10.0M |
| Dividends Per Share | — | — | — | — | — | — | — | — |